Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_provenance.
- NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_provenance.
- NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_assertion evidence source_evidence_literature NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_provenance.
- NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_assertion SIO_000772 14578204 NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_provenance.
- NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_assertion wasDerivedFrom befree-20150227 NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_provenance.
- NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_assertion wasGeneratedBy ECO_0000203 NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_provenance.